Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program

PURPOSE: The aim of this study was to confirm the efficacy and safety of regorafenib for advanced gastrointestinal stromal tumors (GISTs) reported in the GRID phase III trial in Korean patients. MATERIALS AND METHODS: Fifty-seven Korean patientswith advanced GISTwho experienced both imatinib and sun...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Res Treat
Asıl Yazarlar: Son, Myoung Kyun, Ryu, Min-Hee, Park, Joon Oh, Im, Seock-Ah, Kim, Tae-Yong, Lee, Su Jin, Ryoo, Baek-Yeol, Park, Sook Ryun, Kang, Yoon-Koo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Korean Cancer Association 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398393/
https://ncbi.nlm.nih.gov/pubmed/27456941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.067
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller